122 related articles for article (PubMed ID: 38104284)
1. Investigation of the IL7Rα Gene Polymorphism rs6897932 and the Expression Levels of the CDH1, TTPAL, and FHIT Genes in Patients with Breast Cancer.
Arikan-Soylemez ES; Çilekar M; Akici M; Tokyol Ç; Özyürek HA; Söylemez Z; Solak M
P R Health Sci J; 2023 Dec; 42(4):283-290. PubMed ID: 38104284
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the expression levels of CDH1, FHIT, PTEN, and TTPAL genes in colorectal tumors.
Arıkan Söylemez ESS; Söylemez Z; Çilekar M; Arıkan Y; Tokyol Ç; Kenger İH; Solak M
Turk J Med Sci; 2022 Feb; 52(1):124-130. PubMed ID: 36161592
[TBL] [Abstract][Full Text] [Related]
3. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 7 Receptor Alpha Gene Variants Are Correlated with Gene Expression in Patients with Relapsing-remitting Multiple Sclerosis.
Sayad A; Omrani MD; Solgi G; Noroozi R; Arsang-Jang S; Inoko H; Taheri M
Iran J Allergy Asthma Immunol; 2017 Aug; 16(4):338-346. PubMed ID: 28865414
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the interleukin-7 receptor α gene and mortality in untreated HIV-infected individuals.
Hartling HJ; Thørner LW; Erikstrup C; Zinyama R; Kallestrup P; Gomo E; Nielsen SD; Ullum H
AIDS; 2013 Jun; 27(10):1615-20. PubMed ID: 23462217
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
8. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
9. No association between rs6897932 in the gene encoding interleukin-7 receptor α and low-grade inflammation or self-reported health - results from the Danish Blood Donor Study.
Hartling HJ; Sørensen CJ; Rigas AS; Burgdorf KS; Nielsen SD; Pedersen OB; Petersen MS; Sørensen E; Kotzé S; Thørner LW; Hjalgrim H; Erikstrup C; Ullum H
APMIS; 2015 Feb; 123(2):169-74. PubMed ID: 25421942
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
Tavakolpour S
Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877
[TBL] [Abstract][Full Text] [Related]
11. The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Medrano LM; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Saura-Montalbán J; Vázquez-Morón S; Ryan P; Resino S
PLoS One; 2018; 13(5):e0197115. PubMed ID: 29742149
[TBL] [Abstract][Full Text] [Related]
12. Association of E-cadherin single-nucleotide polymorphisms with the increased risk of breast cancer: a study in South Indian women.
Tipirisetti NR; Govatati S; Govatati S; Kandukuri LR; Cingeetham A; Singh L; Digumarti RR; Bhanoori M; Satti V
Genet Test Mol Biomarkers; 2013 Jun; 17(6):494-500. PubMed ID: 23551055
[TBL] [Abstract][Full Text] [Related]
13. [CDH1 polymorphism and its association with the risk of cervical cancer].
Zhou RM; Wang N; Sun DL; Duan YN; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):56-9. PubMed ID: 19563064
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
15. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility].
Aristizábal-Pachón AF; Takahashi CS
Biomedica; 2016 Dec; 36(4):593-602. PubMed ID: 27992986
[TBL] [Abstract][Full Text] [Related]
16. Association of
Rahim A; Zakiullah ; Jan A; Ali J; Khuda F; Muhammad B; Khan H; Shah H; Akbar R
Afr Health Sci; 2022 Sep; 22(3):145-154. PubMed ID: 36910346
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract][Full Text] [Related]
18. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
19. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
[TBL] [Abstract][Full Text] [Related]
20. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
